Prophylactic platelet transfusions prior to surgery for people with a low platelet count
Referencias
Additional references
Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, et al. Thrombocytopenia associated with chronic liver disease. Journal of Hepatology 2008;48(6):1000‐7.
BCSH. British Committee for Standards in Haematology: guidelines for the use of platelet transfusions. British Journal of Haematology 2003;122(1):10‐23.
Birchall J, Tinegate H, Regan F. Chapter 14 Acute transfusion reactions (ATR). In: Bolton‐Maggs PHB, Poles D, et al.on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group, editor(s). The 2014 Annual SHOT Report. Manchester, UK: SHOT, 2015:106–12.
Blumberg N, Heal JM, Phillips GL. Platelet transfusions: trigger, dose, benefits and risks. F1000 Medicine Reports 2010;2:1‐5.
Bolton‐Maggs PHB, (Ed) Poles D, et al. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2015 Annual SHOT Report. SHOT2016.
Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. American Journal of Obstetrics and Gynecology 1990;162:731‐4.
Cameron B, Rock G, Olberg B, Neurath D. Evaluation of platelet transfusion triggers in a tertiary‐care hospital. Transfusion 2007;47(2):206‐11.
Chapman C. Transfusion‐related lung injury (TRALI), 2015. www.shotuk.org/wp‐content/uploads/SHOT‐2014‐Annual‐Report_v11‐Web‐Edition.pdf (accessed 26 November 2015).
Veritas Health Innovation. Covidence systematic review software. Melbourne: Veritas Health Innovation, 2016.
Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: HigginsJPT, Green S (editors). Cochrane Handbook for SystematicReviews of Interventions Version 5.1.0 (updated March2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Desborough MJR, Smethurst PA, Estcourt LJ, Stanworth SJ. Alternatives to allogeneic platelet transfusion. British Journal of Haematology 2016;175:381–92.
Desborough MJ, Oakland K, Brierley C, Bennett S, Doree C, Trivella M, et al. Desmopressin use for minimising perioperative blood transfusion. Cochrane Database of Systematic Reviews 2017, Issue 7. [DOI: 10.1002/14651858.CD001884.pub3]
Engele LJ, Straat M, van Rooijen IHM, de Vooght KMK, Cremer OL, Schultz M, et al. Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill. Annals of Intensive Care 2016;6:67. [DOI: 10.1186/s13613‐016‐0173‐1.]
Effective Practice, Organisation of Care (EPOC). EPOC Resources for review authors. Oslo: Norwegian KnowledgeCentre for the Health Services 2015. Available at: http://epoc.cochrane.org/epoc–specific–resources–review–authors.
Estcourt LJ, Birchall J, Lowe D, Grant‐Casey J, Rowley M, Murphy MF. Platelet transfusions in haematology patients: are we using them appropriately?. Vox Sanguinis 2012;103(4):284‐93.
Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, et al. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database of Systematic Reviews 2016, Issue 3. [DOI: 10.1002/14651858.CD009733.pub3]
Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, et al. and the British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. British Journal of Haematology 2017;176:365‐94. [DOI: 10.1111/bjh.14423]
Fabes J, Barker G, Simons G, Curry N, Brunskill SJ, Doree C, et al. Pro‐coagulant haemostatic factors for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010649]
Fuller AK, Uglik KM, Braine HG, King KE. A comprehensive program to minimize platelet outdating. Transfusion 2011;51:1469–76. [DOI: 10.1111/j.1537‐2995.2010.03039.x]
Greeno E, McCullough J, Weisdorf D. Platelet utilization and the transfusion trigger: a prospective analysis. Transfusion 2007;47:201–5. [DOI: 10.1111/j.1537‐2995.2007.01089.x]
Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD001886.pub4]
Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in Statistics. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 2011;139(2):271‐8.
Jacobs MR, Smith D, Heaton WA, Zantek ND, Good CE. Detection of bacterial contamination in prestorage culture‐negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion 2011;51(12):2573–82.
Joint Formulary Committee. Joint Formulary Committee. British National Formulary. Online. London: BMJ Group and Pharmaceutical Press, 2016. Available at: https://www.medicinescomplete.com/mc/bnf/current. Accessed 17th March 2016.
Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2015;162(3):205–13.
Kuter DJ. Milestones in understanding platelet production: a historical overview. British Journal of Haematology 2014;165(2):248‐58.
Leguit RJ, van den Tweel JG. The pathology of bone marrow failure. Histopathology 2010;57(5):655‐70.
Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Journal of Haematology 2009;145(1):24‐33.
McNicol ED, Tzortzopoulou A, Schumann R, Carr DB, Kalra A. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database of Systematic Reviews 2016, Issue 9. [DOI: 10.1002/14651858.CD006883.pub3]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta‐Analyses: the PRISMA Statement. Annals of Internal Medicine 2009;151(4):264–9.
Neunert CE. Current management of immune thrombocytopenia. Hematology 2013;2013:276‐82.
NICE. Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura. National Institute of Health and Care Excellence2011:TA221.
NICE. Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205). National Institute of Health and Care Excellence2013:TA293.
National Institute for Health and Clinical Excellence. Blood transfusion. https://www.nice.org.uk/guidance/ng24 Accessed 10 November 2016.
Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S. Prevalence and characterization of thrombocytopenia in pregnancy in Indian women. Indian Journal of Hematology and Blood Transfusion 2012;28(2):77‐81.
Pacheco LD, Berkowitz RL, Moise KJ, Bussel JB, McFarland JG, Saade GR. Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstetrics and Gynecology 2011;118(5):1157‐63.
Parmar M, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815–34.
Pendry K, Davies T. An audit of use and wastage in the north west of England and North Wales: where have all the platelets gone?. Blood and Transplant Matters 2011;34:17‐9.
Perdigão JPV, de Almeida PC, Rocha TDS, Mota MRL, Soares ECS, Alves APNN, et al. Postoperative bleeding after dental extraction in liver pretransplant patients. Journal of Oral and Maxillofacial Surgery 2012;70:e177‐84.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton‐Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115(2):168‐86.
Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: Including non‐randomised studies. In: Higgins JPT,Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Revman. The Nordic Cochrane Centre. The Cochrane Collaboration . Review Manager (RevMan). 5.3. The Nordic Cochrane Centre,. The Cochrane Collaboration; Copenhagen, 2014.
Sainio S, Kekomäki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population‐based study. Acta Obstetricia et Gynecologica Scandinavica 2000;79:744‐9.
Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ’Summary of findings’ tables. In: Higgins JPT,Green S (editors), Cochrane Handbook for SystematicReviews of InterventionsVersion 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Availablefrom handbook.cochrane.org.
Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, DeeksJJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD005011.pub4]
Slichter SJ. Evidence‐based platelet transfusion guidelines. Hematology 2007;1520:172‐8.
Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004;44(8):1143‐8.
Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DLA. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion 2013;53(5):1050‐8.
Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. 2011. Available from handbook cochrane.org.
Sterne JAC, Hernán MA, Reeves C, Savović J, Berkman ND, Viswanathan M, et al. ROBINS‐I: a tool for assessing risk of bias in non‐randomised studies of interventions. BMJ 2016;355:i4919.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials 2007;8:16. [DOI: 10.1186/1745‐6215‐8‐16]
Tsimberidou AM, Giles FJ, Khouri I, Bueso‐Ramos C, Pilat S, Thomas DA, et al. Low‐dose interleukin‐11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. Annals of Oncology 2005;16(1):139–45.
Vlaar AP, Juffermans NP. Transfusion‐related acute lung injury: a clinical review. Lancet 2013;382(9896):984‐94.
Weinzierl EP, Arber DA. The differential diagnosis and bone marrow evaluation of new‐onset pancytopenia. American Journal of Clinical Pathology 2013;139(1):9‐29.
Whitaker BI. National Blood Collection and Utilization Survey Report. Washington, DC: U.S. Department of Health and Human Services; 2013. www.hhs.gov/ash/bloodsafety/2011‐nbcus.pdf Accessed 01 December 2016.
Zeng Y, Duan X, Xu J, Ni X. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD008235.pub2]
